The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1193-1200

  Matsushita, Shigeto ^a   Ikeda, Ryuji ^a   Nishizawa, Yukihiko ^a   Che, Xiao Fang ^a   Furukawa, Tatsuhiko ^a   Miyadera, Kazutaka ^b   Tabata, Sho ^a   Ushiyama, Mina ^a   Tajitsu, Yusuke ^a   Yamamoto, Masatatsu ^a   Takeda, Yasuo ^a   Minami, Kentaro ^a   Mataki, Hironori ^a   Kanzaki, Tamotsu ^a   Yamada, Katsushi ^a   Kanekura, Takuro ^a   Akiyama, Shin Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 fluorouracil; FdUMP; Leucovorin; Ternary complex; Thymidine phosphorylase; Thymidylate synthase; TSP 1

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; ENZYME INHIBITOR; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THROMBOSPONDIN 1; THYMIDINE PHOSPHORYLASE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA; CELL LINE, TUMOR; DIDEOXYNUCLEOTIDES; EARLY GROWTH RESPONSE PROTEIN 1; FLUORODEOXYURIDYLATE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; SKIN NEOPLASMS; STOMACH NEOPLASMS; THROMBOSPONDIN 1; THYMIDINE PHOSPHORYLASE; URIDINE MONOPHOSPHATE;

EID: 77950383688     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000602     Document Type: Article

References (49)

1. Iltzsch MH, Kouni MH and Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24: 6799-6807, 1985.
2. Friedkin D and Roberts D: The enzymatic synthesis of nucleosides. J Biol Chem 207: 245-256, 1954.
3. Krenitsky TA, Koszalka GW and Tuttle JV: Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylase. Biochemistry 20: 3615-3621, 1981.
4. Zimmerman M and Seidenberg J: Deoxyribosil transfer. Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J Biol Chem 230: 2618-2621, 1964.
5. Gallo RC, Perry S and Breitman TR: The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. J Biol Chem 242: 5059-5068, 1967.
6. Krenitsky TA: Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylases. J Biol Chem 243: 2871-2875, 1968.
7. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T: Clinico-pathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.
8. Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, Akiyama S and Ohi Y: Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570-2578, 1997.
9. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S and Aikou T: The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 32: 1227-1232, 1996.
10. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada Y, Akiba S, Yamada Y, Sumizawa T and Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996.
11. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onda N, Kato Y and Sowa M: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888, 1996.
12. Koukourakis MI, Giatromanolaki A, O'Bryne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC and Harris AL: Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 75: 477-481, 1997.
13. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC and Harris AL: The angiogenic factor pletelet-derived endothelial cell growth factor/ thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275-280, 1996.
14. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M and Yamada Y: Angiogenic factor. Nature 356: 668, 1992.
15. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S and Yamada Y: Angiogenic activity of enzymes. Nature 368: 198, 1994.
16. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y and Akiyama S: Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55: 1687-1690, 1995.
17. Piper AA and Fox RM: Biochemical basis for the differential sensitivity of human T- and B-lymphocyte lines to 5-fluorouracil. Cancer Res 42: 3753-3760, 1982.
18. Miw M, Cook A and Ishitsuka H: Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. Chem Pharm Bull 34: 4225-4232, 1986.
19. Verez Z, Szabolcs A, Szinai I, Denes G and Jeney A: Enzymatic cleavage of 5-substituted-2′-deoxyuridines by pyrimidine nucleoside phosphorylases. Biochem Pharmacol 35: 1057-1059, 1986.
20. Heidelberger C, Chaudhuri NK, Danenberg P, Mooren D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E and Scheiner J: Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179: 663-666, 1957.
21. Santi DV, McHenry CS and Sommer H: Mechanism of intraction of thymidylate synthase with 5-fluorouracil. Biochemistry 13: 471-481, 1974.
22. Danenberg PV and Lockshin A: Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthase. Pharmacol Ther 13: 69-90, 1981.
23. Zhao HY, Ooyama A, Yamamoto M, Ikeda R, Haraguchi M, Tabata S, Furukawa T, Che XF, Zhang S, Oka T, Fukushima M, Nakagawa M, Ono M, Kuwano M and Akiyama S: Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil. Cancer Res 68: 7035-7041, 2008.
24. Potter H, Weir L and Leder P: Enhancer-dependent expression of human k immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci USA 81: 7161-7165, 1984.
25. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K and Akiyama S: Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034: 107-113, 1990.
26. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
28. Andersen JK: Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10: 203-209, 1984.
29. Carmichael J, DeGraff WG, Gazder AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric Assay: assesment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
30. Inaba M, Mitsuhashi J, Sawada H, Miike N, Naoe Y, Daimon A, Koizumi K, Tsujimoto H and Fukushima M: Reduced activity of anabolizing enzymes in 5-fluorouracil resistant human stomach cancer cells. Jpn J Cancer Res 87: 212-220, 1996.
31. Schwartz EL, Baptiste N, Wadler S and Makower D: Thymidine phosphorylase madiates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270: 19073-19077, 1985.
32. Temmink OH, de Bruin M, Turksma AW, Cricca S, Laan AC and Peters GJ: Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. Int J Biochem Cell Biol 39: 565-575, 2007.
33. Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Straford IJ and Harris AL: Increased sensitivity to the prodrug to 5′-deoxy-5- fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675, 1995.
34. Fox SB, Engels K, Comley M, Whitehouse RM, Turley H, Gatter KC and Harris AL: Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann Oncol 8: 271-275, 1997.
35. Griffiths L and Stratford IJ: Pletelet derived endothelial cell growth factor thymidine phosphorylase in tumour growth and responce to therapy. Br J Cancer 76: 689-693, 1997.
36. Mader RM, Sieder AE, Braun J, Rizovski B, Kalipciyan M, Mueller MW, Jakesz R, Rainer H and Steger GG: Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidines resistance in colon cancer in vitro. Biochem Pharmacol 54: 1233-1242, 1997.
37. Piedbois P, Buyse M and Rustum Y: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer. J Clin Oncol 10: 896-903, 1992.
38. Mansoni S: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939-949, 1995.
39. Washtien WL: Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells. Mol Pharmacol 21: 723-728, 1982.
40. Barbour KW, Berger SH and Berger FG: Single amino acid substitution delines a naturally occurring genetic variant of human thymidylate synthase. Mol Pharmacol 37: 515-518, 1990.
41. Tai N, Schmitz JC, Liu J, Lin X, Bailly M, Chen TM and Chu E: Translational autoregulation of thymidylate synthase and dihydrofolate reductase. Front Biosci 9: 2521-2526, 2004.
42. Welsh SJ, Titley J, Brunton L, Valenti M, Monaghan P, Jackman AL and Aherne GW: Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. Clin Cancer Res 6: 2538-2546, 2000.
43. Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J and Eling TE: Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 67: 356-364, 2005.
44. Shingu T and Bornstein P: Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J Biol Chem 269: 32551-32557, 1994.
45. Liu C, Yao J, Mercola D and Adamson E: The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J Biol Chem 275: 20315-20323, 2000.
46. Jiménez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL and Bouck N: Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6: 41-48, 2000.
47. Lawler J: Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6: 1-12, 2002.
48. Yao L, Zhao YL, Itoh S, Wada S, Yue L and Furuta I: Thrombospondin-1 expression in oral squamous cell carcinomas: correlations with tumor vascularity, clinicopathological features and survival. Oral Oncol 36: 539-544, 2000.
49. Bocci G, Francia G, Man S, Lawler J and Kerbel RS: Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc Natl Acad Sci USA 100: 12917-12922, 2003.